Transaminase

Publisher Website
Google Scholar
Abstract
SERUM glutamic oxaloacetic transaminase has recently become widely used as a fairly specific test for the determination of acute myocardial infarction. Many laboratories are evaluating the use of this enzyme in this and many other clinical states to determine its specificity, advantages and shortcomings, but as yet the time has been too short for the accumulation of a great number of cases for adequate statistical evaluation. For the most part the reports in the literature are preliminary studies. A review of the subject, however, might acquaint the clinician with some knowledge of when to ask for the test, when it . . .